Structure and function of the enigmatic Sec14 domain-containing proteins and the etiology of human disease

Future Lipidology

Volumn 3, Issue 4, 2008, Pages 399-410

  Curwin, Amy J ^a   McMaster, Christopher R ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

GTPase; Human disease; Phospholipid; Retinaldehyde; Tocopherol; Vesicular transport

Indexed keywords

CAYTAXIN; CELL PROTEIN; CRAL TRIO DOMAIN; LIPID BINDING PROTEIN; NEUROFIBROMIN; PROTEIN BMCC1; PROTEIN BNIP 2; PROTEIN BNIPL; PROTEIN CRALBP1; SEC14 DOMAIN CONTANING PROTEIN; SNARE PROTEIN; THYMIDINE TRIPHOSPHATE;

ALPHA TOCOPHEROL DEFICIENCY; ATAXIA; CRYSTAL STRUCTURE; FUNGAL GENE; HUMAN; HUMAN GENOME; LIVER CELL CARCINOMA; NEUROFIBROMATOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; RETINA DISEASE; RETINITIS PIGMENTOSA; REVIEW; SACCHAROMYCES CEREVISIAE; STRUCTURE ACTIVITY RELATION;

EUKARYOTA; SACCHAROMYCES CEREVISIAE;

EID: 48649094898     PISSN: 17460875     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460875.3.4.399     Document Type: Review

References (88)

1. Crabb JW, Carlson A, Chen Y et al.: Structural and functional charactarization of recombinant human cellular retinaldehyde-binding protein. Protein Sci., 7, 746-757 (1998).
2. D'Angelo I, Welti S, Bonneau F, Scheffzek K: A novel bipartite phospholipid-binding module in the neurofibromatosis type 1 protein. EMBO Rep. 7, 174-179 (2006).
3. Schaaf G, Orrlund EA, Tyeryar KR et al.: Functional anatomy of phospholipid binding and regulation of phosphoinositide homeostasis by proteins of the sec14 superfamily. Mol. Cell 29, 191-206 (2008).
4. Sha B, Phillips SE, Bankaitis VA, Luo M: Crystal structure of the Saccharomyces cerevisiae phosphatidylinositol-transfer protein. Nature 391, 506-510 (1998).
5. Stocker A, Tomizaki T, Schulze-Briese C, Baumann U: Crystal structure of the human supernatant protein factor. Structure 10, 1533-1540 (2002).
6. Saito K, Tautz L, Mustelin T. The lipid-binding SEC14 domain. Biochim. Biophys. Acta 1771, 719-726 (2007).
7. Mousley CJ, Tyeryar KR, Vincent-Pope P, Bankaitis VA: The Sec14-superfamily and the regulatory interface between phospholipid metabolism and membrane trafficking. Biochim. Biophys. Acta 1771, 727-736 (2007).
8. Min KC, Kovall RA, Hendrickson WA: Crystal structure of human α-tocopherol transfer protein bound to its ligand: implications for ataxia with vitamin E deficiency. Proc. Natl Acad. Sci. USA 100, 14713-14718 (2003).
9. Schaaf G, Betts L, Garrett TA, Raetz CR, Bankaitis VA: Crystallization and preliminary x-ray diffraction analysis of phospholipid-bound Sfh1p, a member of the Saccharomyces cerevisiae Sec14p-like phosphatidylinositol transfer protein family. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 62, 1156-1160 (2006).
10. Ryan MM, Temple BR, Phillips SE, Bankaitis VA: Conformational dynamics of the major yeast phosphatidylinositol transfer protein sec14p: insight into the mechanisms of phospholipid exchange and diseases of sec14p-like protein deficiencies. Mol. Biol. Cell 18, 1928-1942 (2007).
11. Li X, Routt SM, Xie Z et al.: Identification of a novel family of nonclassic yeast phosphatidylinositol transfer proteins whose function modulates phospholipase D activity and Sec14p-independent cell growth. Mol. Biol. Cell 11, 1989-2005 (2000).
12. Skinner HB, Alb JG Jr, Whitters EA, Helmkamp GM Jr, Bankaitis VA: Phospholipid transfer activity is relevant to but not sufficient for the essential function of the yeast SEC14 gene product. EMBO J. 12, 4775-4784 (1993).
13. Cleves A-E, McGee TP, Whitters EA et al.: Mutations in the CDP-choline pathway for phospholipid biosynthesis bypass the requirement for an essential phospholipid transfer protein. Cell 64, 789-800 (1991).
14. Maw MA, Kennedy B, Knight A et al.: Mutation of the gene encoding cellular, retinaldehyde-binding protein in autosomal recessive retinnis pigmentosa. Nat. Genet. 17, 198-200 (1997).
15. Bomar JM, Benke PJ, Slattery EL et al.: Mutations in a novel gene encoding a CRAL-TRIO domain cause human Cayman ataxia and ataxia/ dystonia in the jittery mouse. Nat. Genet. 35, 264-269 (2003).
16. Manor D, Morley S: The α-tocopherol transfer protein. Vitam. Horm. 76, 45-65 (2007).
17. Eichers ER, Green JS, Stockton DW et al.: Newfoundland rod-cone dystrophy, an early-onset retinal dystrophy, is caused by splice-junction mutations in RLBP1. Am. J. Hum. Genet. 70, 955-964 (2002).
18. Burstedt MS, Forsman-Semb K, Golovleva I, Janurager T, Wachtmeister L, Sandgren O: Ocular phenotype of bothnia dystrophy, an autosomal recessive retinitis pigmentosa associated with an R234W mutation in the RLBP1 gene. Arch. Ophthalmol. 119, 260-267 (2001).
19. Zhao S, Xu C, Qian H et al.: Cellular retinaidehyde-binding protein-like (CRALBPL), a novel human Sec14p-like gene that is upregulated in human hepatocellular carcinomas, may be used as a marker for human hepatocellular carcinomas. DNA Cell Biol. 27(3), 159-163 (2008).
20. Qian J, Atkinson J, Manor D: Biochemical consequences of heritable mutations in the α-tocopherol transfer protein. Biocbemistry 45, 8236-8242 (2006).
21. Hosomi A, Arita M, Sato Y et al.: Affinity for α-rocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett. 409, 105-108 (1997).
22. Xiao J, Gong S, Ledoux MS: Caytaxin deficiency disrupts signaling pathways in cerebellar cortex. Neuroscience 144, 439-461 (2007).
23. Low BC, Lim YP, Lim J, Wong ES, Guy GR: Tyrosine phosphorylation of the Bcl-2-associated protein BNIP-2 by fibroblast growth factor receptor-1 prevents its binding to Cdc42GAP and Cdc42. J. Mol. Chem. 274, 33123-33130 (1999).
24. Sirokmany G, Szidonya L, Kaldi K, Gaborik Z, Ligeti E, Geiszt M: Sec14 homology domain targets p50RhoGAP to endosomes and provides a link between Rab and Rho GTPases. J. Biol. Chem. 281, 6096-6105 (2006).
25. Qin W, Hu. J, Guo M et al.: BNIPL-2, a novel homologue of BNIP-2, interacts with Bcl-2 and Cdc42GAP in apoptosis. Biochem. Biohys. Res. Commun. 308, 379-385 (2003).
26. Machida T, Fujita T, Ooo ML et al.: Increased expression of proapoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with favorable prognosis in human neuroblastomas. Oncogene 25, 1931-1942 (2006).
27. Rossman KL, Der CJ, Sondek J: GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat. Rev. Mol. Cell Biol. 6, 167-180 (2005).
28. Yoshizuka N, Moriuchi R, Mori T et al.: An alternative transcript derived fiom the trio locus encodes a guanosine nucleotide exchange factor with mouse cell-transforming potential. J. Mol. Chem. 279, 43998-44004 (2004).
29. Ueda S, Kataoka T, Satoh T: Role of the Sec14-like domain of Dbl family exchange factors in the regulation of Rho family GTPases in different subcellular sites. Cell Signal 16, 899-906 (2004).
30. Kostenko, EV, Mahon GM, Cheng L, Whitehead IP: The Sec14 homology domain regulates the cellular distribution and transforming activity of the Rho-specific guanine nucleotide exchange factor Dbs. J. Biol Chem. 280, 2807-2817 (2005).
31. McPherson CE, Eipper BA, Mains RE: Multiple novel isoforms of Trio are expressed in the developing rat brain. Gene 347, 125-135 (2005).
32. Sun YJ, Nishikawa K, Yuda H et al.: Solo/Trio8, a membrane-associated short isoform of Trio, modulates endosome dynamics and neurite elongation. Mol. Cell Biol. 26, 6923-6935 (2006).
33. Moskwa P, Paclet MH, Dagher MC, Ligeti E: Autoinhibition of p50 Rho GTPase-activating protein (GAP) is released by prenylated small GTPases. J. Biol. Chem. 280, 6716-6720 (2005).
34. White R, Viskochil D, O'Connell P: Identification and characterization of the gene for neurofibromatosis type 1. Curr. Opin. Neurobiol. 1, 462-467 (1991).
35. Bankaitis VA, Aitken JR, Cleves AE, Dowhan W: An essential role for a phospholipid transfer protein in yeast Golgi function. Nature 347, 561-562 (1990).
36. Bankaitis VA, Malehorn DE, Emr SD, Greene R: The Saccharomyces cerevisiae SEC14 gene encodes a cytosolic factor that is required for transport of secretory proteins from the yeast Golgi complex. J. Cell-Biol. 108, 1271-1281 (1989).
37. Fairn GD, Curwin AJ, Stefan CJ, McMaster CR: The oxysterol binding protein Kes1p regulates Golgi apparatus phosphatidylinositol-4-phosphate function. Proc. Natl Acad. Sci. USA 104, 15352-15357 (2007).
38. Henneberry AL, Lagace TA, Ridgway ND, McMaster CR: Phosphatidylcholine synthesis influences the diacylglycerol homeostasis required for SEC14p-dependent Golgi function and cell growth. Mol. Biol. Cell 12, 511-520 (2001).
39. Murray JP, McMaster CR: Nte1p-mediated deacylation of phosphatidylcholine functionally interacts with Sec14p. J. Biol. Chem. 280, 8544-8552 (2005).
40. Sreenivas A, Patton-Vogt JL, Brune V, Griac P, Henry SA: A role for phospholipase D (Pld1p) in growth, secretion, and regulation of membrane lipid synthesis in yeast. J. Biol. Chem. 273, 16635-16638 (1998).
41. Xie Z, Fang M, Bankaitis VA: Evidence for an intrinsic toxicity of phosphatidylcholine to Sec14p-dependent protein transport from the yeast Golgi complex. Mol. Biol Cell 12, 1117-1129 (2001).
42. Xie Z, Fang M, Rivas MP et al.: Phospholipase D activity is required for suppression of yeast phosphatidylinositol transfer protein defects. Proc. Natl Acad. Sci. USA 95, 12346-12351 (1998).
43. Cleves AE, Novick PJ, Bankaitis VA: Mutations in the SAC1 gene suppress defects in yeast Golgi and yeast actin function. J. Cell Biol. 109, 2939-2950 (1989).
44. Novick P, Field C, Schekman R: Identification of 23 complementation groups required for post-translational events in the yeast secretory pathway. Cell 21, 205-215 (1980).
45. Howe AG, Fairn GD, MacDonald K, Bankaitis VA, McMaster CR: Regulation of phosphoinositide levels by the phospholipid transfer protein Sec14p controls Cdc42p/p21-activated kinase-mediated cell cycle progression at cytokinesis. Eukaryot. Cell 6, 1814-1823 (2007).
46. Wong TA, Fairn GD, Poon PP et al.: Membrane metabolism mediated by Sec14 family members influences Arf GTPase activating protein activity for transport from the trans-Golgi. Proc. Natl Acad. Sci. USA 102, 12777-12782 (2005).
47. Yanagisawa LL, Marchena J, Xie Z et al.: Activity of specific lipid-regulated ADP ribosylation factor-GTPase-activating proteins is required for Sec14p-dependent Golgi secretory function in yeast. Mol. Biol. Cell 13, 2193-2206 (2002).
48. Robinson M, Poon PP, Schindler C et al.: The Gcs1 Arf-GAP mediates Snc1,2 v-SNARE retrieval to the Golgi in yeast. Mol. Biol. Cell 17, 1845-1858 (2006).
49. Behnia R, Munro S: Organelle identity and the signposts for membrane traffic. Nature 438, 597-604 (2005).
50. Di Paolo G, De Camilli P: Phosphoinositides in cell regulation and membrane dynamics. Nature 443, 651-657 (2006).
51. Demmel L, Gravert M, Ercan E et al.: The clathrin adaptor Gga2p is a phosphatidylinositol 4-phosphate effector at the Golgi exit. Mol. Biol Cell 19, 1991-2002 (2008).
52. De Matteis MA, Di Campli A, Godi A: The role of the phosphoinositides at the Golgi complex. Biochim. Biophys. Acta 1744, 396-405 (2005).
53. Chen SH, Chen S, Tokarev AA, Liu F, Jedd G, Segev N: Ypt31/32 GTPases and their novel F-box effector protein Rcy1 regulate protein recycling. Mol. Biol Cell 16, 178-192 (2005).
54. Anantharaman V, Aravind L: The GOLD domain, a novel protein module involved in Golgi function and secretion. Genome Biol. 3(5), research0023 (2002).
55. Gotoda T, Arita M, Arai H et al.: Adult-onset spinocerebellar dysfunction caused by a mutation in the gene for the α-tocopherol-transfer protein. N. Engl. J. Med. 333, 1313-1318 (1995).
56. Panagabko C, Morley S, Hernandez M et al.: Ligand specificity in the CRAL-TRIO protein family. Biochemistry 42, 6467-6474 (2003).
57. Yokota T, Shiojiri T, Gotoda T et al.: Friedreich-like ataxia with retinitis pigmentosa caused by the His101 Gln mutation of the α-tocopherol transfer protein gene. Ann. Neurol. 41, 826-832 (1997).
58. Burstedt MS, Sandgren O, Holmgren G, Forsman-Semb K: Bothnia dystrophy caused by mutations in the cellular retinaldehyde-binding protein gene (RLBP1) on chromosome 15q26. Invest. Qphthalmol. Vis. Sci. 40, 995-1000 (1999).
59. Fishman GA, Roberts MF, Derlacki DJ et al.: Novel mutations in the cellular retinaldehyde-binding protein gene (ALBP1I) associated with retinitis punctata albescens: evidence of interfamilial genetic heterogeneity and fundus changes in heterozygotes. Arch. Ophthalmol. 122, 70-75 (2004).
60. Kong YH, Ye GM, Qu K et al.: Cloning and characterization of a novel, human cellular retinaldehyde-binding protein CRALBP-like (CRALBPL) gene. Biotechnol. Lett. 28, 1327-1333 (2006).
61. Kong YH, Ye GM, Qu K et al.: Cloning and characterization of a novel, human cellular retinaldehyde-binding protein CRALBP-like (CRALBPL) gene. Biotechnol. Lett. 28, 1327-1333 (2006).
62. Shibata N, Arita M, Misaki Y et al.: Supernatant protein factor, which stimulates the conversion of squalene to lanosterol, is a cytosolic squalene transfer protein and enhances cholesterol biosynthesis. Proc. Natl Acad Sci. USA 98, 2244-2249 (2001).
63. Zimmer S, Stocker A, Sarbolouki MN, Spycher SE, Sassoon J, Azzi A: A novel human tocopherol-associated protein: cloning, in vitro expresision, and characterization. J. Biol. Chem. 275, 25672-25680 (2000).
64. Porter TD: Supernatant protein factor and tocopherol-associated protein: an unexpected link between cholesterol synthesis and vitamin E (review). J. Nutr. Biochem. 14, 3-6 (2003).
65. Kempna P, Zingg JM, Ricciarelli R, Hierl M, Saxena S, Azzi A: Cloning of novel human SEC14p-like proteins: ligand binding and functional properties. Free Radic. Biol. Med. 34, 1458-1472 (2003).
66. Ye X, Ji C, Yin G et al.: Characterization of a human Sec14-like protein cDNA SEC14L3 highly homologous to human SPF/TAP. Mol. Biol Rep. 31, 59-63 (2004).
67. Ribeiro FM, Ferreira LT, Marion S et al.: SEC14-like protein 1 interacts with cholinergic transporters. Neurochem. Int. 50, 356-364 (2007).
68. Zhao R, Fu X, Li Q, Krantz SB, Zhao ZJ: Specific interaction of protein tyrosine phosphatase-MEG2 with phosphatidylserine. J. Biol. Chem. 278, 22609-22614 (2003).
69. Huynh H, Wang X, Li W et al.: Homotypic secretory vesicle fusion induced by the protein tyrosine phosphatase MEG2 depends on polyphosphoinositides in T cells. J. Immunol. 171, 6661-6671 (2003).
70. Kruger JM, Fulcushima T, Cherepanov V et al.: Protein-tyrosine phosphatase MEG2 is expressed by human neutrophils. Localization to the phagosome and activation by polyphosphoinositides. J. Biol. Chem. 277, 2620-2628 (2002).
71. Krugmann S, Anderson KE, Ridley SH et al.: Identification of ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, by selective capture on phosphoinositide affinity matrices. Mol. Cell 9, 95-108 (2002).
72. Boyd JM, Malstrom S, Subramanian T et al.: Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell 79, 341-351 (1994).
73. Zhou YT, Soh UJ, Shang X, Guy GR, Low BC: The BNIP-2 and Cdc42GAP homology/Sec14p-like domain of BNIP-Sα is a novel apoprosis-inducing sequence. J. Biol. Chem. 277, 7483-7492 (2002).
74. Valencia CA, Cotten SW, Liu R: Cleavage of BNIP-2 and BNIP-XL by caspases. Biochem. Biophys. Res. Commun. 364, 495-501 (2007).
75. Greenman C, Stephens P, Smith R et al.: Patterns of somatic mutation in human cancer genomes. Nature 446, 153-158 (2007).
76. Seipel K, Medley QG, Kedersha NL, et al.: Trio amino-terminal guanine nucleotide exchange factor domain expression Promotes actin cytoskeleton reorganization, cell migration and anchorage-independent cell growth J. Cell Sci. 112(Pt 12), 1825 1831 (1999).
77. Colomer V, Engelender S, Sharp AH et al.: Huntingtin-associated protein 1 (HAP1) binds to a Trio-like polypeptide, with a rac1 guanine nucleotide exchange factor domain. Hum. Mol. Genet. 6, 1519-1525 (1997).
78. Wang L, Hauser ER, Shah SH et al.: Peakwide mapping on chromosome 3q13 identifies the kalirin gene as a novel candidate gene for coronary artery disease. Am. J. Hum. Genet. 80, 650-663 (2007).
79. Komai K, Okayama R, Kitagawa M, Yagi H, Chihara K, Shiozawa S: Alternative splicing variants of the human DBL (MCF-2) proto-oncogene. Biochem. Biophys. Res. Commun. 299, 455-458 (2002).
80. Sahai E, Marshall CJ: RHO-GTPases and cancer. Nat. Rev. Cancer 2, 133-142 (2002).
81. Johnstone C-N, Castellvi-Bel 9, Chang LM et al.: ARHGAP8 is a novel member of the RHOGAP family related to ARHGAP1/CDC42GAP/p50RHOGAP: mutation and expression analyses in colorectal and breast cancers. Gene 336, 59-71 (2004).
82. Kluwe L, Tatagiba M, Funsterer C, Mautner VF: NF1 mutations and clinical spectrum in patients with spinal neurofibromas. J. Med. Genet. 40, 368-371 (2003).
83. Marchuk DA, Saulino AM, Tavakkol R et al.: cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics 11, 931-940 (1991).
84. De Luca A, Bottillo I, Sarkozy A et al.: NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome. Am. J. Hum. Genet. 77, 1092-1101 (2005).
85. Sjoblom T, Jones S, Wood LD et al.: The consensus coding sequences of human breast and colorectal cancers. Science 314, 268-274 (2006).
86. Hasle H, Arico M, Basso G et al.: Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. European Working Group on MDS in Childhood (EWOG-MDS). Leukemia 13, 376-385 (1999).
87. Ota T, Suzuki Y, Nishikawa T et al.: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat. Genet. 36, 40-45 (2004).
88. Shang X, Zhou YT, Low BC: Concerted regulation of cell dynamics by BNIP-2 and Cdc42GAP homology/Sec14p-like, proline-rich, and GTPase-activating protein domains of a novel Rho GTPase-activating protein, BPGAP1. J. Biol. Chem. 278, 45903-45914 (2003).